SHOULDER INNOVATIONS, INC. Selling, General and Administrative Expense
SHOULDER INNOVATIONS, INC. (SI) reported Selling, General and Administrative Expense of $20.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $20.09M, a 56.32% increase year-over-year.
- SHOULDER INNOVATIONS, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $18.21M, a 73.38% increase year-over-year.
- SHOULDER INNOVATIONS, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $16.34M, a 78.83% increase year-over-year.
- SHOULDER INNOVATIONS, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $15.08M, a 77.54% increase year-over-year.
- SHOULDER INNOVATIONS, INC. selling, general and administrative expense for fiscal 2025 was $54.77M, a 58.72% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. selling, general and administrative expense for fiscal 2024 was $34.51M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.09M 10-Q · filed 2026-08-06 | $38.29M 10-Q · filed 2026-08-06 | $54.63M derived: sum of 3 quarters · filed 2026-08-06 | $69.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $18.21M 10-Q · filed 2026-05-13 | $34.55M derived: sum of 2 quarters · filed 2026-05-13 | $49.63M derived: sum of 3 quarters · filed 2026-05-13 | $62.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $16.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $31.42M derived: sum of 2 quarters · filed 2026-03-10 | $44.27M derived: sum of 3 quarters · filed 2026-08-06 | $54.77M 10-K · filed 2026-03-10 |
| 2025-09-30 | $15.08M 10-Q · filed 2025-11-12 | $27.93M derived: sum of 2 quarters · filed 2026-08-06 | $38.43M 10-Q · filed 2025-11-12 | $47.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $12.85M 10-Q · filed 2026-08-06 | $23.35M 10-Q · filed 2026-08-06 | $32.49M derived: sum of 3 quarters · filed 2026-08-06 | $40.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $10.50M 10-Q · filed 2026-05-13 | $19.64M derived: sum of 2 quarters · filed 2026-05-13 | $28.13M derived: sum of 3 quarters · filed 2026-05-13 | $37.30M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $17.63M derived: sum of 2 quarters · filed 2026-03-10 | $26.80M derived: sum of 3 quarters · filed 2026-03-10 | $34.51M 10-K · filed 2026-03-10 |
| 2024-09-30 | $8.49M 10-Q · filed 2025-11-12 | $17.66M derived: sum of 2 quarters · filed 2025-11-12 | $25.37M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $9.17M 10-Q · filed 2025-09-09 | $16.88M 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |